IL11 and cancer: We report that stromal LMO2 over-expression can stimulate secretion of interleukin-11 (IL-11) which facilitates proliferation and invasiveness of either prostate epithelial or cancer cells via IL-11 – IL-11 receptor α (IL11Rα) – STAT3 signaling pathway.